Application no. and date | 07859236.7 (espacenet) (Federated) (European Patent Register), 20071016 | Patent/reg. no. and date | DK/EP 2076540, 20190227 | Publication date | 20090708 | Priority no. and date | EP 06291628, 20061019 | EP pub. no. and date |
EP 2076540 20090708 | Effective date | | Applicant/owner | Sanofi-Aventis U.S. LLC, 55 Corporate Drive
Bridgewater, NJ 08807, US | Applicant ref. no. | SAN FR2006/043-EP-EPT[07859236.7] | Inventor | PARK, Peter U., c/o ImmunoGen Inc. 830 Winter Street
Waltham, MA 02451, US, BARTLE, Laura M., c/o ImmunoGen Inc. 830 Winter Street
Waltham, MA 02451, US, GOLMAKHER, Viktor S., c/o ImmunoGen Inc. 830 Winter Street
Waltham, MA 02451, US, TAVARES, Daniel, c/o ImmunoGen Inc. 830 Winter Street
Waltham, MA 02451, US, DECKERT, Jutta, c/o ImmunoGen Inc. 830 Winter Street
Waltham, MA 02451, US, SKALETSKAYA, Anna, 128 Sidney Street
Cambridge, MA 02139, US, MIKOL, VINCENT, c/o Sanofi-Aventis Département des Brevets 174, Avenue de France
75013 Paris, FR, BLANC, Véronique, c/o Sanofi-Aventis Département des Brevets 174, Avenue de France
75013 Paris, FR | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | C07K 16/28 (2006.01) | Title | HIDTIL UKENDTE ANTI-CD38-ANTISTOFFER TIL BEHANDLING AF CANCER | Int. application no. | IB2007004172 | Int. publication no. | WO2008047242 | Related patent (certificate) | CA 2020 00051 | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|